U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) saw unusually-strong trading volume on

Ginkgo Bioworks and Eli Lilly announced a partnership last month focused on AI drug discovery. The s

In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $12.5, denot

Nasdaq fell 150+ points, while Everpure jumped 14% after unveiling growth plans and a FY2028 outlook

Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a select

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.58, marking a -8.43

Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1%

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that its Ginkgo Datapoints offe

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that it has been awarded a subc

BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintain

- Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $

Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str

Prada Group CEO Andrea Guerra speaks to CNBC's Charlotte Reed about global luxury consumers, keeping

Ginkgo Bioworks NYSE: DNA reported second-quarter 2026 revenue of $20 million, down 48% from the yea

TD Cowen analyst Brendan Smith downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Buy to Hold an

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings Call Transcript

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a global leader in payments

DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth i

CoreWeave (NASDAQ: CRWV) and Nebius Group (NASDAQ: NBIS | NBIS Price Prediction) just delivered Q1 2

Caxton Associates LLP lowered its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) by 6

Gene-editing is a handy tool for developing sophisticated medicines. A new CRISPR molecule can destr

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today

Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq

https://www.cdc.gov/ebola/situation-summary/index.html

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transf

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers th

Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinos

Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interf

Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robot

Ginkgo today announced it has reached an agreement to sell the Company's biosecurity business to

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the

Ginkgo Bioworks (NYSE:DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI

TD Cowen analyst Brendan Smith maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy and lower

Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement o

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector

Ginkgo Bioworks (NYSE:DNA) today announced it has been awarded by the Environmental Molecular Scienc

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its

Ginkgo Bioworks Holdings (NYSE:DNA) affirms FY2025 sales outlook from $167.000 million-$187.000 mill

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.45) per share which missed the